Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.

Post-translational modifications enable extra layers of control of the proteome, and perhaps the most important is proteolysis, a major irreversible modification affecting every protein. The intersection of the protease web with a proteome sculpts that proteome, dynamically modifying its state and function. Protease expression is distorted in cancer, so perturbing signaling pathways and the secretome of the tumor and reactive stromal cells. Indeed many cancer biomarkers are stable proteolytic fragments. It is crucial to determine which proteases contribute to the pathology versus their roles in homeostasis and in mitigating cancer. Thus the full substrate repertoire of a protease, termed the substrate degradome, must be deciphered to define protease function and to identify drug targets. Degradomics has been used to identify many substrates of matrix metalloproteinases that are important proteases in cancer. Here we review recent degradomics technologies that allow for the broadly applicable identification and quantification of proteases (the protease degradome) and their activity state, substrates, and interactors. Quantitative proteomics using stable isotope labeling, such as ICAT, isobaric tags for relative and absolute quantification (iTRAQ), and stable isotope labeling by amino acids in cell culture (SILAC), can reveal protease substrates by taking advantage of the natural compartmentalization of membrane proteins that are shed into the extracellular space. Identifying the actual cleavage sites in a complex proteome relies on positional proteomics and utilizes selection strategies to enrich for protease-generated neo-N termini of proteins. In so doing, important functional information is generated. Finally protease substrates and interactors can be identified by interactomics based on affinity purification of protease complexes using exosite scanning and inactive catalytic domain capture strategies followed by mass spectrometry analysis. At the global level, the N terminome analysis of whole communities of proteases in tissues and organs in vivo provides a full scale understanding of the protease web and the web-sculpted proteome, so defining metadegradomics.

[1]  X. Puente,et al.  Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.

[2]  F. Melchior,et al.  Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.

[3]  X. Puente,et al.  Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.

[4]  Marc W. Kirschner,et al.  How Proteolysis Drives the Cell Cycle , 1996, Science.

[5]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[6]  C. Boyault,et al.  Regulation of protein turnover by acetyltransferases and deacetylases. , 2008, Biochimie.

[7]  Y. Hoshida,et al.  Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment , 2005, Proteomics.

[8]  Christopher M Overall,et al.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.

[9]  Jill L. Wegrzyn,et al.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. , 2008, Annual review of pharmacology and toxicology.

[10]  J. Clancy,et al.  A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation12 , 2008, The Journal of Immunology.

[11]  J. Whelan,et al.  Processing of the dual targeted precursor protein of glutathione reductase in mitochondria and chloroplasts. , 2004, Journal of molecular biology.

[12]  M. Pelto-huikko,et al.  Shedding light on ADAM metalloproteinases. , 2005, Trends in biochemical sciences.

[13]  S. Dower,et al.  Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. , 1994, Journal of immunology.

[14]  Bonnie F. Sloane,et al.  Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment , 2007, Molecular Cancer Research.

[15]  L. Cantley,et al.  Determination of protease cleavage site motifs using mixture-based oriented peptide libraries , 2001, Nature Biotechnology.

[16]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[17]  S. Stoch,et al.  Cathepsin K Inhibitors: A Novel Target for Osteoporosis Therapy , 2008, Clinical pharmacology and therapeutics.

[18]  J. Coorssen,et al.  Enhanced detergent extraction for analysis of membrane proteomes by two-dimensional gel electrophoresis , 2005, Proteome Science.

[19]  Markus Müller,et al.  Quantitative Proteomic Analysis of Protein Complexes , 2008, Molecular & Cellular Proteomics.

[20]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[21]  James R. Knight,et al.  A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.

[22]  J. Thigpen,et al.  CA 15–3 and c-erbB-2 presence in the saliva of women , 1999, Clinical Oral Investigations.

[23]  N. Seyfried,et al.  Systematic approach for validating the ubiquitinated proteome. , 2008, Analytical chemistry.

[24]  P. Griffin,et al.  Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. , 1994, Biochemistry.

[25]  Stephen L. Sazinsky,et al.  Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3 , 2007, Protein science : a publication of the Protein Society.

[26]  Christopher M. Overall,et al.  Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer , 2006, Cancer and Metastasis Reviews.

[27]  V. Hintze,et al.  The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains , 2007, Biological chemistry.

[28]  J. Garin,et al.  An Optimized Strategy for ICAT Quantification of Membrane Proteins* , 2006, Molecular & Cellular Proteomics.

[29]  A. Hermetter,et al.  Activity-based proteomics: enzymatic activity profiling in complex proteomes , 2006, Amino Acids.

[30]  R. Beynon,et al.  Positional proteomics: preparation of amino-terminal peptides as a strategy for proteome simplification and characterization , 2006, Nature Protocols.

[31]  D. Bataille Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology , 2007, Journal of Molecular Medicine.

[32]  B. Sachais,et al.  The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. , 2007, Blood.

[33]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[34]  C. López-Otín,et al.  Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.

[35]  H. Ploegh,et al.  Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. , 2001, Chemistry & biology.

[36]  G. Plowman,et al.  The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. , 1992, The Journal of biological chemistry.

[37]  Y. Dong,et al.  Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma. , 2007, Pathology, research and practice.

[38]  R. Aebersold,et al.  Mass Spectrometry and Protein Analysis , 2006, Science.

[39]  Nasreen S Jessani,et al.  Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Walsh,et al.  A Binding Site for Heparin in the Apple 3 Domain of Factor XI* , 1998, The Journal of Biological Chemistry.

[41]  C. Overall,et al.  Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis , 1999, The Journal of Biological Chemistry.

[42]  J. Fox,et al.  Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: identification of two novel substrates with functional relevance. , 2007, Archives of biochemistry and biophysics.

[43]  B. Séraphin,et al.  The tandem affinity purification (TAP) method: a general procedure of protein complex purification. , 2001, Methods.

[44]  B. Cravatt,et al.  Profiling serine hydrolase activities in complex proteomes. , 2001, Biochemistry.

[45]  K. Sakaguchi,et al.  Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth , 1998, The Journal of experimental medicine.

[46]  Kim Ys,et al.  Human protein digestion and absorption: normal mechanisms and protein-energy malnutrition. , 1983 .

[47]  Robert Huber,et al.  The crystal structure of the proprotein processing proteinase furin explains its stringent specificity , 2003, Nature Structural Biology.

[48]  J. Drews Drug discovery: a historical perspective. , 2000, Science.

[49]  K. Terpe Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems , 2002, Applied Microbiology and Biotechnology.

[50]  K. Ishii,et al.  Processing and Functions of Hepatitis C Virus Proteins , 1999, Intervirology.

[51]  B. Séraphin,et al.  A generic protein purification method for protein complex characterization and proteome exploration , 1999, Nature Biotechnology.

[52]  Guanghui Wang,et al.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. , 2006, Journal of Proteome Research.

[53]  M. Haine,et al.  Van Damme A. , 1986 .

[54]  C. Overall,et al.  Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. , 1990, The Journal of biological chemistry.

[55]  A. Burlingame,et al.  Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.

[56]  J. Gordon,et al.  Proteolytic processing and compartmentalization of the primary translation products of mammalian apolipoprotein mRNAs. , 1986, CRC critical reviews in biochemistry.

[57]  C. Overall,et al.  Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.

[58]  P. Vandenabeele,et al.  Caspase-containing complexes in the regulation of cell death and inflammation , 2006, Biological chemistry.

[59]  K. Gevaert,et al.  Improved recovery of proteome‐informative, protein N‐terminal peptides by combined fractional diagonal chromatography (COFRADIC) , 2008, Proteomics.

[60]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Wiseman,et al.  Determination of enzyme specificity in a complex mixture of peptide substrates by N-terminal sequence analysis. , 1991, Analytical biochemistry.

[62]  M. MacCoss,et al.  Quantitative Profiling of Ubiquitylated Proteins Reveals Proteasome Substrates and the Substrate Repertoire Influenced by the Rpn10 Receptor Pathway*S , 2007, Molecular & Cellular Proteomics.

[63]  C. Vanpouille,et al.  Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Darius Moradpour,et al.  Structural biology of hepatitis C virus. , 2003, Clinics in liver disease.

[65]  A. Barrett Bioinformatics of proteases in the MEROPS database. , 2004, Current opinion in drug discovery & development.

[66]  A. Bauch,et al.  An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells , 2006, Nature Methods.

[67]  Z. Werb ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.

[68]  Z. Darżynkiewicz,et al.  In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors. , 2002, Experimental hematology.

[69]  R. Baserga,et al.  A modified tandem affinity purification tag technique for the purification of protein complexes in mammalian cells , 2005, Proteomics.

[70]  K. Suzuki,et al.  Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. , 1994, The Journal of biological chemistry.

[71]  W. Stetler-Stevenson,et al.  Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. , 2004, The Biochemical journal.

[72]  V. Cryns,et al.  Proteases to die for. , 1998, Genes & development.

[73]  M. Parmentier,et al.  Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. , 2007, Blood.

[74]  T. Peretz,et al.  Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival , 2007, British Journal of Cancer.

[75]  H. Ragab,et al.  Soluble cytokeratin-19 and E-selectin biomarkers: their relevance for lung cancer detection when tested independently or in combinations. , 2008, Cancer biomarkers : section A of Disease markers.

[76]  T. Rapoport,et al.  A signal sequence receptor in the endoplasmic reticulum membrane , 1987, Nature.

[77]  E. Raines,et al.  Emerging roles for ectodomain shedding in the regulation of inflammatory responses , 2006, Journal of leukocyte biology.

[78]  R. Aebersold,et al.  Identification of Putative Androgen Receptor Interaction Protein Modules , 2007, Molecular & Cellular Proteomics.

[79]  K. Downard,et al.  Ions of the interactome: The role of MS in the study of protein interactions in proteomics and structural biology , 2006, Proteomics.

[80]  G. Dubin,et al.  Proteinaceous cysteine protease inhibitors , 2005, Cellular and Molecular Life Sciences.

[81]  Jeffrey W. Smith,et al.  Profiling constitutive proteolytic events in vivo. , 2007, The Biochemical journal.

[82]  N. D. Da Silva,et al.  Sequential cloned gene integration in the yeast Kluyveromyces lactis , 2003, Applied Microbiology and Biotechnology.

[83]  H. Ploegh,et al.  A closer look at proteolysis and MHC-class-II-restricted antigen presentation. , 2002, Current opinion in immunology.

[84]  B. Wiederanders,et al.  Functions of propeptide parts in cysteine proteases. , 2003, Current protein & peptide science.

[85]  Thierry Meinnel,et al.  The Proteomics of N-terminal Methionine Cleavage*S , 2006, Molecular & Cellular Proteomics.

[86]  B. Fingleton Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects , 2003, Expert opinion on therapeutic targets.

[87]  Wei Wang,et al.  Identification of Novel Protein-Protein Interactions Using A Versatile Mammalian Tandem Affinity Purification Expression System* , 2003, Molecular & Cellular Proteomics.

[88]  P. Young,et al.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Crystal,et al.  Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. , 1981, Science.

[90]  S. H. Baek,et al.  Deubiquitinating enzymes: their diversity and emerging roles. , 1999, Biochemical and biophysical research communications.

[91]  C. Overall,et al.  Towards third generation matrix metalloproteinase inhibitors for cancer therapy , 2006, British Journal of Cancer.

[92]  R. Campbell,et al.  Homodimerization of calpain 3 penta-EF-hand domain. , 2005, The Biochemical journal.

[93]  C. Craik,et al.  MT-SP1 proteolysis and regulation of cell-microenvironment interactions. , 2008, Frontiers in bioscience : a journal and virtual library.

[94]  B. Vallee,et al.  Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.

[95]  C. Overall,et al.  The Hemopexin-like Domain (C Domain) of Human Gelatinase A (Matrix Metalloproteinase-2) Requires Ca2+ for Fibronectin and Heparin Binding , 1997, The Journal of Biological Chemistry.

[96]  Ruedi Aebersold,et al.  The study of macromolecular complexes by quantitative proteomics , 2003, Nature Genetics.

[97]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[98]  R. Huber,et al.  Structural basis of the endoproteinase-protein inhibitor interaction. , 2000, Biochimica et biophysica acta.

[99]  D. Picard Hsp90 invades the outside , 2004, Nature Cell Biology.

[100]  Gary Walsh,et al.  Post-translational modifications in the context of therapeutic proteins , 2006, Nature Biotechnology.

[101]  N. Thornberry,et al.  A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE). , 1997, Chemistry & biology.

[102]  Francesco Leonetti,et al.  Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin , 2000, Nature Biotechnology.

[103]  N. Ridgway,et al.  Caspase Processing and Nuclear Export of CTP:Phosphocholine Cytidylyltransferase α during Farnesol-Induced Apoptosis , 2002, Molecular and Cellular Biology.

[104]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[105]  Matthias Mann,et al.  Innovations: Functional and quantitative proteomics using SILAC , 2006, Nature Reviews Molecular Cell Biology.

[106]  M. Mann,et al.  A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.

[107]  T. Köcher,et al.  An efficient protein complex purification method for functional proteomics in higher eukaryotes , 2003, Nature Biotechnology.

[108]  M. Ryan,et al.  Translating the message. , 2001, Biologist.

[109]  P. Heinrich,et al.  Control of proteolysis. , 1980, Annual review of biochemistry.

[110]  S. M. Park,et al.  A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. , 2004, Biochimica et biophysica acta.

[111]  M. Mann,et al.  Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). , 2003, Journal of proteome research.

[112]  C. Ioannou,et al.  Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. , 1993, European journal of biochemistry.

[113]  Zhiheng He,et al.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis , 2003, Journal of Molecular Medicine.

[114]  J. Wallace,et al.  Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. , 2002, Blood.

[115]  Zbynek Bozdech,et al.  Biochemical Analysis of the 20 S Proteasome of Trypanosoma brucei * , 2003, The Journal of Biological Chemistry.

[116]  L. Tarassishin,et al.  Stereoselective Synthesis of Photoreactive Peptidomimetic γ-Secretase Inhibitors , 2004 .

[117]  Gillian Murphy,et al.  The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.

[118]  Vincent Collura,et al.  From protein-protein complexes to interactomics. , 2007, Sub-cellular biochemistry.

[119]  J. Baselga,et al.  Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis , 2006, Molecular and Cellular Biology.

[120]  R. Beynon,et al.  Positional proteomics: selective recovery and analysis of N-terminal proteolytic peptides , 2005, Nature Methods.

[121]  M. Mann,et al.  Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK) , 2006, Nature Methods.

[122]  K. Gevaert,et al.  Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis , 2005, Nature Methods.

[123]  A. R. Khan,et al.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes , 1998, Protein science : a publication of the Protein Society.

[124]  J. Thigpen,et al.  A Preliminary Study of CA15-3, c-erbB-2, Epidermal Growth Factor Receptor, Cathepsin-D, and p53 in Saliva Among Women with Breast Carcinoma , 2000, Cancer investigation.

[125]  R. Aebersold,et al.  Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics , 2004, Nature Structural &Molecular Biology.

[126]  E. Wolf,et al.  The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.

[127]  J. Wells,et al.  Substrate phage: selection of protease substrates by monovalent phage display. , 1993, Science.

[128]  P. Bork,et al.  Proteome survey reveals modularity of the yeast cell machinery , 2006, Nature.

[129]  H. Meisel Multifunctional peptides encrypted in milk proteins , 2004, BioFactors.

[130]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[131]  G. Salvesen,et al.  Identification of proteolytic cleavage sites by quantitative proteomics. , 2007, Journal of proteome research.

[132]  J. Hutton,et al.  Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases , 1994, Diabetologia.

[133]  M. Mann,et al.  Analysis of proteins and proteomes by mass spectrometry. , 2001, Annual review of biochemistry.

[134]  J. Daurès,et al.  Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[135]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[136]  S. Chattopadhaya,et al.  Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. , 2004, Journal of the American Chemical Society.

[137]  D. Edwards,et al.  The ADAMTS metalloproteinases. , 2005, The Biochemical journal.

[138]  Randy J. Read,et al.  Structure of a serpin–protease complex shows inhibition by deformation , 2000, Nature.

[139]  T. Ley,et al.  A proteomic approach for the discovery of protease substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[140]  Christine Gaboriaud,et al.  X-ray Structure of the Ca2+-binding Interaction Domain of C1s , 2003, Journal of Biological Chemistry.

[141]  C. Overall,et al.  Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP) , 2004, Journal of Biological Chemistry.

[142]  C. Overall,et al.  Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding , 2008, Molecular and Cellular Biology.

[143]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[144]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[145]  J. Beckmann,et al.  Identification of putative in vivo substrates of calpain 3 by comparative proteomics of overexpressing transgenic and nontransgenic mice , 2006, Proteomics.

[146]  F. Sherman,et al.  N-terminal acetyltransferases and sequence requirements for N-terminal acetylation of eukaryotic proteins. , 2003, Journal of molecular biology.

[147]  S. Jentsch,et al.  Membrane-bound transcription factors: regulated release by RIP or RUP. , 2001, Current opinion in cell biology.

[148]  Oliver Schilling,et al.  Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites , 2008, Nature Biotechnology.

[149]  J. Kirsch,et al.  A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[151]  C. Overall,et al.  Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co , 2007, Molecular and Cellular Biology.

[152]  P. Cohen,et al.  The origins of protein phosphorylation , 2002, Nature Cell Biology.

[153]  X. Puente,et al.  Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. , 2008, Cancer research.

[154]  S. Levine,et al.  Mechanisms of Soluble Cytokine Receptor Generation , 2004, The Journal of Immunology.

[155]  B. Cauwe,et al.  The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases , 2007, Critical reviews in biochemistry and molecular biology.

[156]  J. Rine,et al.  Modulation of Ras and a-Factor Function by Carboxyl-Terminal Proteolysis , 1997, Science.

[157]  B. Cravatt,et al.  Activity-based protein profiling: the serine hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[158]  S. Higashiyama,et al.  ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. , 2005, Biochimica et biophysica acta.

[159]  A. Burlingame,et al.  Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.

[160]  Y. Bourbonnais,et al.  Anti-inflammatory activity of neutrophil elastase inhibitors. , 2003, Current opinion in investigational drugs.

[161]  J. Riordan,et al.  Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. , 1991, Biochemistry.

[162]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[163]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[164]  C. Overall Molecular determinants of metalloproteinase substrate specificity , 2002, Molecular biotechnology.

[165]  F. De Ceuninck,et al.  High binding capacity of cyclophilin B to chondrocyte heparan sulfate proteoglycans and its release from the cell surface by matrix metalloproteinases: possible role as a proinflammatory mediator in arthritis. , 2003, Arthritis and rheumatism.

[166]  S. Zucker,et al.  Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.

[167]  Wei Li,et al.  Extracellular heat shock protein‐90α: linking hypoxia to skin cell motility and wound healing , 2007, The EMBO journal.

[168]  P. Bork,et al.  Functional organization of the yeast proteome by systematic analysis of protein complexes , 2002, Nature.

[169]  Georges von Degenfeld,et al.  Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.

[170]  P. Reinemer,et al.  The metzincins — Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc‐peptidases , 1995, Protein science : a publication of the Protein Society.

[171]  A. Ciechanover Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. , 2006, Experimental biology and medicine.

[172]  J. White ADAMs: modulators of cell-cell and cell-matrix interactions. , 2003, Current opinion in cell biology.

[173]  T. Renné,et al.  Mapping of the Discontinuous Kininogen Binding Site of Prekallikrein , 1996, The Journal of Biological Chemistry.

[174]  C. Overall,et al.  Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometry. , 2007, Current pharmaceutical design.

[175]  M. Rincón,et al.  Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells1 , 2008, The Journal of Immunology.

[176]  P. Vandenabeele,et al.  Proteome-wide Identification of HtrA2/Omi Substrates. , 2007, Journal of proteome research.

[177]  Alexey I Nesvizhskii,et al.  Analysis and validation of proteomic data generated by tandem mass spectrometry , 2007, Nature Methods.

[178]  Gary D Bader,et al.  Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry , 2002, Nature.

[179]  K. Mann,et al.  Zymogen/enzyme discrimination using peptide chloromethyl ketones. , 1989, The Journal of biological chemistry.

[180]  C. López-Otín,et al.  Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.

[181]  Christopher M Overall,et al.  Proteomics Discovery of Metalloproteinase Substrates in the Cellular Context by iTRAQ™ Labeling Reveals a Diverse MMP-2 Substrate Degradome*S , 2007, Molecular & Cellular Proteomics.

[182]  M. Stack,et al.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[183]  P. Hasselgren,et al.  Catabolic response to stress and potential benefits of nutrition support. , 2002, Nutrition.

[184]  Lan Huang,et al.  An Integrated Mass Spectrometry-based Proteomic Approach , 2006, Molecular & Cellular Proteomics.

[185]  L. Foster,et al.  Cell-based identification of natural substrates and cleavage sites for extracellular proteases by SILAC proteomics. , 2009, Methods in molecular biology.

[186]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[187]  R. Huber,et al.  Natural protein proteinase inhibitors and their interaction with proteinases. , 1992, European journal of biochemistry.

[188]  F. Colland,et al.  Targeting ubiquitin specific proteases for drug discovery. , 2008, Biochimie.

[189]  William C. Parks,et al.  Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.

[190]  R. Aebersold,et al.  A uniform proteomics MS/MS analysis platform utilizing open XML file formats , 2005, Molecular systems biology.

[191]  R. Aebersold,et al.  Analysis of protein complexes using mass spectrometry , 2007, Nature Reviews Molecular Cell Biology.

[192]  C. Craik,et al.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[193]  K. Entian,et al.  Carbon Source-dependent Assembly of the Snf1p Kinase Complex in Candida albicans* , 2005, Journal of Biological Chemistry.

[194]  K. Gevaert,et al.  Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides , 2003, Nature Biotechnology.

[195]  K. Brew,et al.  Tissue inhibitors of metalloproteinases: evolution, structure and function. , 2000, Biochimica et biophysica acta.

[196]  C. Overall,et al.  The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation* , 1998, The Journal of Biological Chemistry.

[197]  Hyojin Cho,et al.  Additional MDA‐MB‐231 breast cancer cell matrix metalloproteinases promote invasiveness , 2008, Journal of cellular physiology.

[198]  Christopher M. Overall,et al.  In search of partners: linking extracellular proteases to substrates , 2007, Nature Reviews Molecular Cell Biology.

[199]  Juergen Kast,et al.  Identification of protein‐protein interactions using in vivo cross‐linking and mass spectrometry , 2004, Proteomics.

[200]  C. Overall,et al.  Stromal cell‐derived factors 1α and 1β, inflammatory protein‐10 and interferon‐inducible T cell chemo‐attractant are novel substrates of dipeptidyl peptidase 8 , 2008, FEBS letters.

[201]  C. Hashimoto,et al.  Signal transduction by a protease cascade. , 1999, Trends in cell biology.

[202]  Z. Werb,et al.  Proteomic Identification of In Vivo Substrates for Matrix Metalloproteinases 2 and 9 Reveals a Mechanism for Resolution of Inflammation1 , 2006, The Journal of Immunology.

[203]  B. Turk Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.

[204]  G. Butler,et al.  The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.

[205]  C. Overall,et al.  Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics , 2002, Biological chemistry.